- Eli Lilly offers savings programs for commercially insured Zepbound patients that can significantly reduce out-of-pocket costs
- Self-pay programs may also be available at reduced prices for patients without insurance coverage
- Stacking insurance coverage with savings cards minimizes your total cost
- PEAK helps you find all available savings options so you pay the least possible
Important GLP-1 safety warning: Zepbound carries a boxed warning for thyroid C-cell tumors. Avoid use in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2.
Eli Lilly’s Zepbound savings program
Eli Lilly, the manufacturer of Zepbound (tirzepatide), offers a manufacturer savings card designed to reduce what patients pay at the pharmacy. The program is intended for patients who have commercial insurance and whose plan covers Zepbound.
Manufacturer savings cards are common in the pharmaceutical industry. They function as a secondary payer — after your insurance processes the claim, the savings card covers part or all of the remaining copay or coinsurance. The result is a lower out-of-pocket cost at the pharmacy counter.
Savings cards help bridge the gap between what insurance covers and what patients can afford. For high-cost specialty medications like Zepbound, the copay alone can be a barrier to starting or staying on treatment. Lilly’s savings program is designed to remove that barrier for commercially insured patients.
Eligibility requirements
The Zepbound savings card is not available to everyone. Eli Lilly sets specific eligibility criteria that determine who qualifies.
General eligibility requirements include:
- Commercial insurance — You must have private or employer-sponsored health insurance. The savings card is designed to work alongside commercial plans.
- Plan covers Zepbound — Your insurance plan must include Zepbound on its formulary and approve coverage. The savings card typically applies to your remaining copay or coinsurance after insurance processes the claim.
- Not government-funded insurance — Patients with Medicare (including Part D), Medicaid, TRICARE, VA benefits, or other government-funded programs are not eligible for the manufacturer savings card. This is a federal requirement, not a Lilly policy.
- U.S. residents — The program is generally limited to patients filling prescriptions at U.S. pharmacies.
Note: PEAK accepts commercial insurance and TRICARE. We do not accept Medicare or Medicaid.
Manufacturer savings programs are updated periodically. Eligibility requirements, savings amounts, and program duration can change at any time. Always verify current terms through your provider or the Eli Lilly website before relying on specific program details.
Savings amounts
The amount you save depends on several factors: your insurance plan’s copay structure, the specific savings program in effect when you fill your prescription, and any caps or limits Lilly places on the program.
What commercially insured patients should understand:
- Copay reduction — The savings card covers a portion of your copay or coinsurance after insurance has processed the claim. Patients with coverage have historically seen significant copay reductions through the program.
- Monthly fill limits — The savings card typically applies to one fill per month (a 28- or 30-day supply). It generally does not cover extra fills or quantities beyond the standard monthly prescription.
- Annual or lifetime caps — Some savings programs include a maximum total savings amount per year or over the life of the program. Once the cap is reached, the card stops providing benefits for the remainder of that period.
- Program duration — Savings programs may be offered for a limited time or renewed at Lilly’s discretion. There is no guarantee that terms available today will remain the same in future months.
The savings card does not change what your insurance covers — it reduces what you pay out of pocket after insurance has done its part.
How to activate
Activating the Zepbound savings card is a straightforward process, but the exact steps may depend on how the program is structured at the time you enroll.
Common activation methods include:
- Lilly’s website. Visit the Zepbound section of Eli Lilly’s website and look for the savings card or savings program page. You will typically need to provide basic information and confirm eligibility. You may receive a digital card with a BIN, PCN, and group number to present at the pharmacy.
- Your provider’s office. Many prescribing clinicians, including PEAK, can help you enroll in the savings program during your appointment. We can provide the card details or activate the card on your behalf as part of our cost navigation process.
- At the pharmacy. In some cases, your pharmacist may be able to apply the savings card at the point of sale. Bring any card details you have received — physical or digital — and ask the pharmacy to run it as a secondary payer after your insurance processes.
The savings card should be set up before you pick up your prescription. If you arrive at the pharmacy without the card details, you may pay full copay and need to seek retroactive reimbursement — which is often more complicated. At PEAK, we help you activate the card before your prescription is sent to the pharmacy.
Self-pay savings
For patients whose insurance does not cover Zepbound — or who do not have insurance at all — Eli Lilly has at times offered cash-pay programs at reduced prices. These programs are separate from the manufacturer savings card and are designed for a different patient population.
Self-pay options have included:
- Direct-to-patient programs — Lilly has offered programs through platforms like LillyDirect that allow eligible patients to purchase Zepbound at a reduced cash price, bypassing insurance entirely. These programs have provided meaningful discounts compared to the full retail price.
- Telehealth partnerships — Some self-pay programs have been offered in conjunction with telehealth platforms, bundling the consultation and prescription together at a set price.
- Limited availability — Self-pay programs are subject to supply constraints, enrollment caps, and Lilly’s discretion. They may not be available at all times or in all regions.
Self-pay pricing and program availability can change with little notice. A price or program that was available last month may not be available today. Always verify current self-pay options directly with Eli Lilly, LillyDirect, or your prescribing provider before making decisions based on a specific price point.
Insurance + savings card strategy
The most cost-effective approach for most patients is to combine insurance coverage with the manufacturer savings card. This stacking strategy minimizes your total out-of-pocket expense.
Here is how the strategy works in practice:
- Get insurance approval first. Work with your provider to obtain prior authorization and confirm that your plan covers Zepbound. Insurance pays the largest portion of the cost.
- Apply the savings card on top. Once insurance processes the claim, the savings card covers part or all of the remaining copay. Your final cost is whatever is left after both insurance and the savings card have been applied.
- Monitor your deductible status. If your plan requires you to meet a deductible before Zepbound is covered, the savings card may not provide full benefit until the deductible is met. In some cases, the savings card payments count toward your deductible; in others, they do not. Check your plan documents or ask your insurer.
| Payment layer | What it covers |
|---|---|
| Insurance (primary) | Covers the bulk of the medication cost after prior authorization approval |
| Savings card (secondary) | Reduces or eliminates the remaining copay or coinsurance |
| Patient (remaining) | Pays whatever remains after insurance and savings card — often very little |
Insurance brings the cost down from list price. The savings card brings your copay down further. Together, they make Zepbound affordable for many patients.
Alternative cost strategies
If the savings card does not fully solve your cost problem — or if you are not eligible — there are additional strategies worth exploring.
- Appeal insurance denials. If your plan denied Zepbound coverage, you have the right to appeal. Many initial denials are overturned on appeal when documentation is thorough. Your clinician can request a peer-to-peer review with the insurance company’s medical director or submit a formal written appeal.
- Sleep apnea coverage pathway. Zepbound received FDA approval for moderate-to-severe obstructive sleep apnea in adults with obesity. If you have a documented sleep apnea diagnosis, your provider may be able to pursue coverage under this indication, which sometimes has different formulary rules than the weight management indication.
- Switch to Wegovy if better covered. If your plan covers Wegovy (semaglutide) but not Zepbound, switching to a covered medication may be a practical solution. Both are FDA-approved GLP-1 receptor agonists for chronic weight management, and your clinician can help determine whether Wegovy is clinically appropriate for you.
- Manufacturer patient assistance programs. Eli Lilly offers patient assistance programs for uninsured or underinsured patients who meet income-based eligibility criteria. These programs may provide the medication at no cost or reduced cost. Eligibility and application details are available through Lilly’s website or through your provider.
PEAK’s cost navigation
Working through savings programs, insurance approvals, and alternative pathways takes time and knowledge. At PEAK, our team handles cost navigation as part of your care — not as an afterthought.
Here is what we do:
- Verify your insurance. Before your first appointment, we check whether your plan covers Zepbound, what your copay structure looks like, and whether prior authorization is required.
- Connect you to savings programs. We enroll eligible patients in the Eli Lilly savings card, help activate the card, and ensure it is applied at the pharmacy. If you qualify for self-pay programs or patient assistance, we guide you through those as well.
- Explore all options. If Zepbound is not covered or remains too expensive after savings programs, we evaluate alternatives — including other covered GLP-1 medications, appeal strategies, and the sleep apnea coverage pathway.
- Provide transparent cost estimates. Before you fill your first prescription, we give you a clear picture of what you will pay. No surprises, no guesswork.
We want cost to be a solved problem, not an ongoing stressor. Every patient at PEAK receives cost navigation support as part of their treatment plan. If a more affordable path exists, we help you find it.







